Northeast Investment Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.9M Sell
85,366
-8,087
-9% -$3.53M 1.25% 25
2026
Q1
$43.1M Buy
93,453
+207
+0.2% +$105K 1.78% 16
2025
Q4
$52.8M Sell
93,246
-492
-0.5% -$262K 2.06% 13
2025
Q3
$41.9M Buy
93,738
+32
+0% +$15.4K 1.69% 14
2025
Q2
$50.9M Buy
93,706
+1,232
+1% +$644K 2.18% 12
2025
Q1
$45.8M Buy
92,474
+3,304
+4% +$1.83M 2.13% 13
2024
Q4
$46.5M Buy
89,170
+2,685
+3% +$1.4M 2.07% 12
2024
Q3
$42.5M Buy
86,485
+3,300
+4% +$1.54M 1.9% 19
2024
Q2
$37M Buy
83,185
+3,874
+5% +$1.54M 1.74% 18
2024
Q1
$31.7M Buy
79,311
+3,671
+5% +$1.39M 1.56% 21
2023
Q4
$25.5M Sell
75,640
-2,272
-3% -$677K 1.37% 26
2023
Q3
$22.8M Sell
77,912
-3,278
-4% -$1.02M 1.34% 25
2023
Q2
$27.8M Sell
81,190
-1,034
-1% -$313K 1.56% 23
2023
Q1
$21M Sell
82,224
-564
-0.7% -$139K 1.27% 26
2022
Q4
$22M Sell
82,788
-832
-1% -$203K 1.4% 26
2022
Q3
$15.7M Buy
83,620
+550
+0.7% +$118K 1.06% 32
2022
Q2
$16.7M Buy
83,070
+698
+0.8% +$164K 1.06% 30
2022
Q1
$24.9M Buy
82,372
+1,176
+1% +$344K 1.31% 25
2021
Q4
$29.2M Sell
81,196
-314
-0.4% -$108K 1.42% 24
2021
Q3
$27M Sell
81,510
-198
-0.2% -$66.5K 1.44% 25
2021
Q2
$25M Sell
81,708
-222
-0.3% -$62.3K 1.35% 25
2021
Q1
$20.2M Buy
81,930
+318
+0.4% +$80K 1.19% 28
2020
Q4
$22.3M Sell
81,612
-405
-0.5% -$101K 1.35% 25
2020
Q3
$19.4M Sell
82,017
-1,620
-2% -$364K 1.29% 25
2020
Q2
$15.9M Sell
83,637
-723
-0.9% -$130K 1.19% 28
2020
Q1
$13.9M Sell
84,360
-5,739
-6% -$1.05M 1.28% 25
2019
Q4
$17.8M Buy
90,099
+1,758
+2% +$329K 1.31% 24
2019
Q3
$15.9M Buy
88,341
+228
+0.3% +$39.4K 1.27% 24
2019
Q2
$15.4M Buy
88,113
+3,693
+4% +$633K 1.22% 26
2019
Q1
$16.1M Buy
84,420
+1,605
+2% +$285K 1.35% 25
2018
Q4
$13.2M Buy
82,815
+1,161
+1% +$197K 1.27% 27
2018
Q3
$15.6M Buy
81,654
+14,601
+22% +$2.59M 1.25% 29
2018
Q2
$10.7M Buy
67,053
+25,632
+62% +$3.91M 0.9% 38
2018
Q1
$5.7M Buy
41,421
+8,922
+27% +$1.25M 0.5% 58
2017
Q4
$3.95M Buy
32,499
+11,880
+58% +$1.49M 0.33% 69
2017
Q3
$2.4M Buy
20,619
+1,503
+8% +$164K 0.21% 76
2017
Q2
$1.99M Buy
19,116
+441
+2% +$42.4K 0.18% 78
2017
Q1
$1.59M Sell
18,675
-261
-1% -$20.6K 0.15% 84
2016
Q4
$1.33M Sell
18,936
-243
-1% -$17.9K 0.13% 89
2016
Q3
$1.54M Buy
19,179
+6,048
+46% +$463K 0.15% 87
2016
Q2
$965K Buy
13,131
+1,269
+11% +$89.3K 0.1% 97
2016
Q1
$792K Buy
11,862
+837
+8% +$51.9K 0.08% 105
2015
Q4
$669K Hold
11,025
0.07% 110
2015
Q3
$563K Hold
11,025
0.06% 110
2015
Q2
$594K Sell
11,025
-1,170
-10% -$65.5K 0.06% 111
2015
Q1
$684K Hold
12,195
0.07% 112
2014
Q4
$717K Sell
12,195
-3,555
-23% -$198K 0.07% 114
2014
Q3
$808K Sell
15,750
-1,800
-10% -$89.4K 0.08% 113
2014
Q2
$803K Hold
17,550
0.08% 111
2014
Q1
$854K Buy
17,550
+2,772
+19% +$131K 0.09% 109
2013
Q4
$631K Sell
14,778
-855
-5% -$36K 0.07% 114
2013
Q3
$654K Sell
15,633
-2,196
-12% -$97K 0.08% 107
2013
Q2
$1M Buy
+17,829
New +$982K 0.13% 91

Other funds holding ISRG

Northeast Investment Management's ISRG Position: Q2 2026 in Review

Northeast Investment Management reduced its Intuitive Surgical (ISRG) stake by 8.7% in Q2 2026, selling an estimated $3.53M and leaving 85,366 shares worth $33.9M. The position accounts for 1.25% of the portfolio, ranked #25.

Northeast Investment Management first reported a position in ISRG in Q2 2013 and has held it in 53 quarters since. The position peaked at $52.8M in Q4 2025. 382 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Northeast Investment Management held 85,366 shares of Intuitive Surgical worth $33.9M as of Q2 2026.
  • Northeast Investment Management sold 8,087 Intuitive Surgical shares in Q2 2026, an estimated $3.53M.
  • Intuitive Surgical made up 1.25% of Northeast Investment Management's portfolio in Q2 2026, its #25 holding.
  • Northeast Investment Management first reported a position in Intuitive Surgical in Q2 2013 and has held it in 53 quarters since.
  • Northeast Investment Management's Intuitive Surgical position peaked at $52.8M in Q4 2025.
  • 382 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.